179 related articles for article (PubMed ID: 17977504)
1. Targeted strategies in the treatment of metastatic colon cancer.
Reidy D; Saltz L
J Natl Compr Canc Netw; 2007 Oct; 5(9):983-90. PubMed ID: 17977504
[TBL] [Abstract][Full Text] [Related]
2. [A perspective: role of targeted therapy in colon cancer].
Chung HH; Jang BI
Korean J Gastroenterol; 2013 Mar; 61(3):128-35. PubMed ID: 23575231
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies in the treatment of advanced colorectal cancer.
Capdevila J; Saura C; Macarulla T; Casado E; Ramos FJ; Tabernero J
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S24-34. PubMed ID: 17981431
[TBL] [Abstract][Full Text] [Related]
4. Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: an Acta Oncologica expert report.
Nygren P; Sørbye H; Osterlund P; Pfeiffer P
Acta Oncol; 2005; 44(3):203-17. PubMed ID: 16076691
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy in colorectal cancer.
Rajpal S; Venook AP
Clin Adv Hematol Oncol; 2006 Feb; 4(2):124-32. PubMed ID: 16728921
[TBL] [Abstract][Full Text] [Related]
6. [Monoclonal antibodies therapies for colorectal cancer: cétuximab, panitumumab and bevacizumab].
Piront P; Van Daele D; Belaiche J; Polus M
Rev Med Liege; 2009; 64(5-6):274-8. PubMed ID: 19642458
[TBL] [Abstract][Full Text] [Related]
7. Integration of novel agents in the treatment of colorectal cancer.
Iqbal S; Lenz HJ
Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S32-9. PubMed ID: 15309512
[TBL] [Abstract][Full Text] [Related]
8. [Molecular target therapy for colonic neoplasms].
Oki E; Ota M; Honbo T; Egashira A; Tokunaga E; Sadanaga N; Morita M; Kakeji Y; Maehara Y
Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):289-94. PubMed ID: 17370595
[No Abstract] [Full Text] [Related]
9. Biologic therapy for colon cancer.
He AR; Marshall J
Clin Adv Hematol Oncol; 2005 Jul; 3(7):555-61. PubMed ID: 16167038
[TBL] [Abstract][Full Text] [Related]
10. TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts.
Damiano V; Caputo R; Garofalo S; Bianco R; Rosa R; Merola G; Gelardi T; Racioppi L; Fontanini G; De Placido S; Kandimalla ER; Agrawal S; Ciardiello F; Tortora G
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12468-73. PubMed ID: 17636117
[TBL] [Abstract][Full Text] [Related]
11. Oncologists' current opinion on the treatment of colon carcinoma.
Majer M; Akerley W; Kuwada SK
Anticancer Agents Med Chem; 2007 Sep; 7(5):492-503. PubMed ID: 17896910
[TBL] [Abstract][Full Text] [Related]
12. Evolving treatment of advanced colon cancer.
Segal NH; Saltz LB
Annu Rev Med; 2009; 60():207-19. PubMed ID: 19630571
[TBL] [Abstract][Full Text] [Related]
13. Biological agents versus chemotherapy in the treatment of colorectal cancer.
Eng C; Shalan N
Expert Opin Pharmacother; 2006 Jul; 7(10):1251-71. PubMed ID: 16805714
[TBL] [Abstract][Full Text] [Related]
14. Researchers describe findings for targeted cancer therapies.
Stephenson J
JAMA; 2000 Jul; 284(3):293-5. PubMed ID: 10891943
[No Abstract] [Full Text] [Related]
15. Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition.
Venook AP
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S74-84. PubMed ID: 19780248
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant bevacizumab and cetuximab for stage III colon cancer: why such failure in an adjuvant situation?].
André T; Larsen AK; de Gramont A
Bull Cancer; 2012 Jun; 99(6):607-8. PubMed ID: 22900267
[No Abstract] [Full Text] [Related]
17. Evolving molecular-based targeted therapy for cancer: an exciting field.
Carneiro B; Hsiao K; Khandekar J
Compr Ther; 2005; 31(4):299-305. PubMed ID: 16407611
[TBL] [Abstract][Full Text] [Related]
18. Targeted therapies in the treatment of colorectal cancers.
Alekshun T; Garrett C
Cancer Control; 2005 Apr; 12(2):105-10. PubMed ID: 15855893
[TBL] [Abstract][Full Text] [Related]
19. First-line treatment of patients with metastatic colorectal cancer: an overview of recent data on chemotherapy plus targeted agents.
Cercek A; Saltz LB
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S47-51. PubMed ID: 19064406
[TBL] [Abstract][Full Text] [Related]
20. Differential response to EGFR- and VEGF-targeted therapies in patient-derived tumor tissue xenograft models of colon carcinoma and related metastases.
Jin K; Lan H; Cao F; Han N; Xu Z; Li G; He K; Teng L
Int J Oncol; 2012 Aug; 41(2):583-8. PubMed ID: 22581265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
